ICER Publishes Final Evidence Report and Policy Recommendations on Treatments for Obesity Management – ICER
Independent appraisal committee voted that evidence is adequate to demonstrate that semaglutide provides a net health benefit compared to lifestyle modification alone; however, at current pricing, semaglutide represents “low” long-term value for money.